FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 332:823 March 23, 1995 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: In their study comparing the rates of allogeneic bone marrow transplantation for chronic myeloid leukemia in 10 countries (Oct. 20 issue), Silberman et al.¹ found that Swedish patients were the most likely to receive transplants. In an editorial in the same issue,² Schroeder discusses possible methodologic reasons for the observed differences. He correctly stresses the importance of the accuracy of the number of cases of chronic myeloid leukemia, as well as the number of bone marrow transplantations. Underestimation of the frequency of the disease in Sweden would lead to overestimation of the country's performance, as compared, for . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.